- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 128 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Report
- September 2023
- 150 Pages
Global
From €2139EUR$2,250USD£1,797GBP
€4278EUR$4,500USD£3,594GBP
- Report
- July 2022
- 150 Pages
Global
From €2139EUR$2,250USD£1,797GBP
- Report
- January 2022
- 60 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- October 2023
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2023
- 189 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2022
Global
From €751EUR$790USD£631GBP
- Report
- August 2022
United States
From €1844EUR$1,940USD£1,549GBP
- Report
- March 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- March 2023
- 132 Pages
Global
From €903EUR$950USD£759GBP

The Muscle Spasm Drug market is a subset of the Central Nervous System Drugs market. It includes drugs used to treat muscle spasms, which are involuntary contractions of the muscles. These drugs are used to reduce pain and discomfort associated with muscle spasms, as well as to improve mobility. Commonly used muscle spasm drugs include muscle relaxants, antispasmodics, and anticonvulsants. These drugs are typically prescribed by a physician and are available in both oral and injectable forms.
The Muscle Spasm Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, GlaxoSmithKline, Merck, and Sanofi. Other companies in the market include AbbVie, AstraZeneca, Teva Pharmaceuticals, and Mylan. Show Less Read more